
Aeglea BioTherapeutics AGLE
Aeglea BioTherapeutics P/CF | AGLE
P/CF Jährlich Aeglea BioTherapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -4.6 | -0.829 | -0.0168 | -0.233 | -5.54 | -3.72 | -5.75 | -4.12 | -2.06 | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.0168 | -5.75 | -2.98 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ADiTx Therapeutics
ADTX
|
-0.00143 | - | - | $ 374 | ||
|
Aeterna Zentaris
AEZS
|
-1.01 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-11.8 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Apellis Pharmaceuticals
APLS
|
61.2 | - | - | $ 5.18 B | ||
|
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | ||
|
AVROBIO
AVRO
|
-0.0396 | - | 1083.1 % | $ 745 M | ||
|
AstraZeneca PLC
AZN
|
9.7 | - | - | $ 96.9 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
EyePoint Pharmaceuticals
EYPT
|
-0.0048 | $ 0.23 | -12.11 % | $ 16.8 K | ||
|
Bio-Path Holdings
BPTH
|
-0.733 | - | - | $ 100 K | ||
|
Cara Therapeutics
CARA
|
-0.049 | - | -3.03 % | $ 260 M | ||
|
ChromaDex Corporation
CDXC
|
35.6 | - | -0.88 % | $ 598 M | ||
|
Caladrius Biosciences
CLBS
|
-0.185 | - | -16.75 % | $ 25.8 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-0.000698 | - | -5.98 % | $ 34.1 M | ||
|
Diffusion Pharmaceuticals
DFFN
|
-1.57 | - | 11.68 % | $ 8.97 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
-8.85 | - | -5.68 % | $ 8.28 M | ||
|
Enochian Biosciences
ENOB
|
-0.183 | - | - | $ 40.5 M | ||
|
Esperion Therapeutics
ESPR
|
-42.9 | - | - | $ 661 M | ||
|
Evofem Biosciences
EVFM
|
-0.431 | - | 7.55 % | $ 38.1 M | ||
|
Eyenovia
EYEN
|
-0.0265 | - | 49.81 % | $ 13.2 M | ||
|
FibroGen
FGEN
|
-0.571 | - | - | $ 889 M | ||
|
Homology Medicines
FIXX
|
-0.672 | - | 0.77 % | $ 53.4 M | ||
|
Amicus Therapeutics
FOLD
|
134 | - | - | $ 4.47 B | ||
|
Frequency Therapeutics
FREQ
|
-0.34 | - | - | $ 528 M | ||
|
Galecto
GLTO
|
-0.0253 | - | - | $ 762 M | ||
|
GlycoMimetics
GLYC
|
-2.88 | - | 9357.83 % | $ 1.01 B | ||
|
Graybug Vision
GRAY
|
-0.0767 | - | -11.23 % | $ 9.65 M | ||
|
Galera Therapeutics
GRTX
|
-0.63 | - | -32.59 % | $ 7.61 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.848 | - | 1.35 % | $ 17.8 M | ||
|
Novavax
NVAX
|
-7.55 | $ 7.47 | -3.24 % | $ 1.21 B | ||
|
Hepion Pharmaceuticals
HEPA
|
-0.115 | - | -18.79 % | $ 39.3 K | ||
|
Hoth Therapeutics
HOTH
|
-1.14 | - | - | $ 18.8 M | ||
|
IMARA
IMRA
|
-3.67 | - | 15.96 % | $ 663 M | ||
|
KalVista Pharmaceuticals
KALV
|
-10.2 | - | - | $ 1.45 B | ||
|
KemPharm
KMPH
|
-6.14 | - | -0.34 % | $ 200 M | ||
|
Kezar Life Sciences
KZR
|
-0.876 | - | - | $ 53.3 M | ||
|
Lixte Biotechnology Holdings
LIXT
|
-8.79 | - | - | $ 63.4 M | ||
|
Magenta Therapeutics
MGTA
|
-0.0979 | - | -7.74 % | $ 41.6 M | ||
|
NovaBay Pharmaceuticals
NBY
|
-0.842 | - | - | $ 11.3 M | ||
|
NeuroBo Pharmaceuticals
NRBO
|
-1.92 | - | 0.43 % | $ 12 M | ||
|
OncoCyte Corporation
OCX
|
-0.0426 | - | 17.22 % | $ 355 K | ||
|
Onconova Therapeutics
ONTX
|
-0.0521 | - | -0.47 % | $ 21 M | ||
|
Opthea Limited
OPT
|
-29.6 | - | - | $ 1.2 B | ||
|
Verastem
VSTM
|
-2.94 | $ 6.33 | -7.8 % | $ 439 M | ||
|
BiomX
PHGE
|
-0.324 | $ 1.85 | 14.2 % | $ 3.02 M |